News | Embolic Protection Devices | September 20, 2016

Claret Medical Submits for U.S. Clearance of TAVR Cerebral Protection System

Filing based on data from the SENTINEL pivotal IDE trial

Claret Medical, Sentinal CPS, cerebral protection system, FDA marketing application, TAVR, embolic protection

September 20, 2016 – Claret Medical announced its filing of a marketing application with the U.S. Food and Drug Administration (FDA) for clearance of the Sentinel Cerebral Protection System (CPS). The Sentinel CPS is designed to protect the brain by capturing and removing debris dislodged during transcatheter aortic valve replacement (TAVR) that enters cerebral circulation and carries the potential for stroke. There are currently no cerebral embolic protection technologies available in the United States to protect TAVR patients from cerebral embolic events, according to Claret Medical.

The filing includes data from the recently completed SENTINEL pivotal investigational device exemption (IDE) trial, a prospective, randomized, controlled, blinded study of 363 TAVR patients at 19 centers in the United States and Germany. Trial endpoints included reduction in new ischemic cerebral infarcts, major adverse cardiac or cerebrovascular events, neurocognitive outcomes, and qualitative and quantitative histopathological findings. The SENTINEL trial allowed inclusion of all commercially available TAVR platforms available in the U.S.

Results from the recently published CLEAN-TAVI blinded, randomized, controlled trial in the Journal of the American Medical Association (JAMA) and the MISTRAL-C randomized, controlled trial, published in Eurointervention, showed that patients protected with the system had significantly fewer and smaller new ischemic cerebral infarcts following the procedure than unprotected patients. MISTRAL-C also demonstrated that the TAVR procedure created embolic debris in 100 percent of patients, which could have traveled to the brain if not for the protection offered by the Sentinel CPS.

Stroke continues to be a devastating complication of TAVR and other endovascular procedures. Ischemic brain infarcts have been associated with adverse neurologic and cognitive consequences, as well as dementia. In population-based studies, they have also been shown to increase the risk of future stroke by two- to four-fold.

The Sentinel CPS received the CE Mark in 2013.

For more information: www.claretmedical.com


Related Content

News | Embolic Protection Devices

April 25, 2023 — FastWave Medical, a privately-held company founded by Big Sky Biomedical partners, announces the ...

Home April 25, 2023
Home
News | Embolic Protection Devices

January 11, 2023 — In recent years, transcatheter mitral valve replacement (TMVR) treatment and technology has evolved ...

Home January 11, 2023
Home
News | Embolic Protection Devices

September 17, 2022 — Boston Scientific Corporation has announced results from the PROTECTED TAVR clinical trial ...

Home September 17, 2022
Home
News | Embolic Protection Devices

February 9, 2021 — InspireMD Inc., developer of the CGuard Embolic Prevention System (EPS) for the prevention of stroke ...

Home February 09, 2021
Home
News | Embolic Protection Devices

August 6, 2019 — Cardiovascular Systems Inc. (CSI) has acquired the Wirion Embolic Protection System and related assets ...

Home August 06, 2019
Home
News | Embolic Protection Devices

July 19, 2019 — Medical device startup company Filterlex Medical recently completed a series A financing round, raising ...

Home July 19, 2019
Home
News | Embolic Protection Devices

August 3, 2018 — Boston Scientific Corp. announced it has recently closed its acquisition of Claret Medical Inc., a ...

Home August 03, 2018
Home
News | Embolic Protection Devices

July 20, 2018 — Boston Scientific Corp. today has signed an agreement to acquire Claret Medical Inc., which has ...

Home July 20, 2018
Home
News | Embolic Protection Devices

June 7, 2018 — The first clinical cases have been completed where the Emboliner Embolic Protection Catheter was used ...

Home June 07, 2018
Home
News | Embolic Protection Devices

May 8, 2018 — One-year results from the Sentinel Cerebral Protection System show it can reduce the incidence of stroke ...

Home May 08, 2018
Home
Subscribe Now